Excerpt from The Guardian

The ad quoted the leader of a clinical trial, Prof David Paterson, saying it was not a stretch to describe the drug as a cure. Drug advertising rules state any therapeutic claim made in relation to novel coronavirus must be supported by appropriate evidence and must not mislead.

Australia’s drug regulator, the Therapeutic Goods Administration, has dropped its investigation into newspaper advertisements taken out by the former federal politician Clive Palmer that described a drug unproven in the treatment of Covid-19 as a “cure”.

In March, the TGA confirmed it was looking into Palmer’s two-page ad in the Australian and on Facebook that stated the drug, hydroxychloroquine, when combined with another medication could “wipe out the virus in test tubes”. The ad also quoted the leader of a clinical trial, Prof David Paterson, saying it was not a stretch to describe the drug as a cure. Drug advertising rules state any therapeutic claim made in relation to novel coronavirus must be supported by appropriate evidence and must not mislead.

The ad said Palmer had agreed to personally fund the acquisition or manufacture of 1m doses “to ensure all Australians would have access to the drug as soon as possible”. On Tuesday, Palmer paid for another series of ads in News Corp papers stating he had since bought 32.9m doses of the drug. The federal government confirmed Palmer has a “written arrangement” with the government to acquire the drug for the national medical stockpile.

The Therapeutic Goods Administration said neither the latest ads nor the previous ones were being investigated. “Assessment of Mr Clive Palmer’s advertisements have been concluded and enforcement action is not warranted,” a TGA spokesman said. “The information was assessed as not intended to promote the sale of the product.”

On 16 March, Paterson had appeared on The Project. When asked by Waleed Aly if it was correct to describe the drug as a “cure” rather than just a treatment, Paterson responded: “Absolutely.”

See the original article here: https://www.theguardian.com/australia-news/2020/apr/28/clive-palmer-ad-for-coronavirus-cure-cleared-by-australian-drug-regulator

Foot note: See some examples of studies and treatments that include hydroxychloroquine, that have considerable success.

Sermo Reports: One-Quarter of Global Physicians Agree That Healthcare Workers Should Take Hydroxychloroquine to Prevent COVID-19 Infections; Use of Hydroxychloroquine in Prophylaxis and Even in Undiagnosed Suspected Patient Cases is Seen

Washington Examiner: Agilum analysis – greatest-number-of-survivors-from-hydroxychloroquine-healthcare-analytics-could-provide-a-blueprint-for-coronavirus-treatments/

Agilum Releases Nationwide COVID-19 Real-World Data (RWD) Survival Rate Analytics

Les Echos – Didier Raoult unveils to Emmanuel Macron a study of 1061 patients, estimating 91% the effectiveness of his treatment against the coronavirus

WHO global megatrial of the four most promising coronavirus treatments includes hydroxychloroquine

Dr. Stephen Smith on effectiveness of hydroxychloroquine: ‘I think this is the beginning of the end of the pandemic’

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »